FI944134A - Virustenvastaisia nukleosidianalogeja - Google Patents
Virustenvastaisia nukleosidianalogeja Download PDFInfo
- Publication number
- FI944134A FI944134A FI944134A FI944134A FI944134A FI 944134 A FI944134 A FI 944134A FI 944134 A FI944134 A FI 944134A FI 944134 A FI944134 A FI 944134A FI 944134 A FI944134 A FI 944134A
- Authority
- FI
- Finland
- Prior art keywords
- antiviral
- nucleocide
- analogues
- substituted
- benzimidazole base
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 229940127073 nucleoside analogue Drugs 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929205071A GB9205071D0 (en) | 1992-03-09 | 1992-03-09 | Therapeutic nucleosides |
| PCT/GB1993/000479 WO1993018009A1 (en) | 1992-03-09 | 1993-03-08 | Antiviral nucleoside analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI944134A0 FI944134A0 (fi) | 1994-09-08 |
| FI944134A true FI944134A (fi) | 1994-11-07 |
Family
ID=10711750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI944134A FI944134A (fi) | 1992-03-09 | 1994-09-08 | Virustenvastaisia nukleosidianalogeja |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5534535A (fi) |
| EP (1) | EP0630368B1 (fi) |
| JP (1) | JP3450854B2 (fi) |
| KR (2) | KR950700887A (fi) |
| AT (1) | ATE170846T1 (fi) |
| AU (1) | AU672597B2 (fi) |
| CA (1) | CA2131693A1 (fi) |
| CZ (1) | CZ209494A3 (fi) |
| DE (1) | DE69320945T2 (fi) |
| DK (1) | DK0630368T3 (fi) |
| ES (1) | ES2123048T3 (fi) |
| FI (1) | FI944134A (fi) |
| GB (1) | GB9205071D0 (fi) |
| HU (1) | HUT68445A (fi) |
| IL (1) | IL104976A (fi) |
| NZ (1) | NZ249554A (fi) |
| RU (1) | RU2141952C1 (fi) |
| TW (1) | TW366339B (fi) |
| WO (1) | WO1993018009A1 (fi) |
| ZA (1) | ZA931647B (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
| GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
| BR9508826A (pt) * | 1994-09-09 | 1997-09-30 | Wellcome Found | Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico |
| US5811073A (en) * | 1995-06-19 | 1998-09-22 | President And Fellows Of Harvard College | Method for radioisotopic detection and localization of inflammation in a host |
| US5912356A (en) * | 1995-09-11 | 1999-06-15 | Glaxo Wellcome Inc. | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
| GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
| GB9600143D0 (en) | 1996-01-05 | 1996-03-06 | Wellcome Found | Therapeutic compounds |
| CA2280761A1 (en) | 1997-02-13 | 1998-08-20 | Stanley Dawes Chamberlain | Benzimidazole derivatives |
| SK284810B6 (sk) * | 1997-05-13 | 2005-12-01 | Lonza Ag | Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu |
| EP0994890B1 (en) | 1997-06-10 | 2003-08-06 | Glaxo Group Limited | Benzimidazole derivatives |
| JP2001512132A (ja) | 1997-07-30 | 2001-08-21 | ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン | 抗ウイルス薬としてのリクソフラノシルベンズイミダゾール |
| US6514979B1 (en) | 1999-03-03 | 2003-02-04 | University Of Maryland Biotechnology Institute | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor |
| GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
| CA2404639A1 (en) | 2000-04-13 | 2001-10-25 | Pharmasset, Ltd. | 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
| JP5479336B2 (ja) * | 2007-08-02 | 2014-04-23 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | Ｅ１活性化酵素阻害剤の合成のためのプロセス |
| MY163114A (en) | 2008-04-28 | 2017-08-15 | Kyorin Seiyaku Kk | Cyclopentylacrylamide derivative |
| US11499722B2 (en) * | 2020-04-30 | 2022-11-15 | Bsh Home Appliances Corporation | Household cooking appliance having an oven door with an interior camera |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996308A (en) * | 1988-03-25 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group |
| ZA894534B (en) * | 1988-06-20 | 1990-03-28 | Merrell Dow Pharma | Novel neplanocin derivatives |
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| GB8926417D0 (en) * | 1989-11-22 | 1990-01-10 | Wellcome Found | Heterocyclic compounds |
| MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| US5248672A (en) * | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
-
1992
- 1992-03-09 GB GB929205071A patent/GB9205071D0/en active Pending
-
1993
- 1993-03-08 HU HU9402582A patent/HUT68445A/hu unknown
- 1993-03-08 IL IL10497693A patent/IL104976A/en not_active IP Right Cessation
- 1993-03-08 EP EP93905536A patent/EP0630368B1/en not_active Expired - Lifetime
- 1993-03-08 NZ NZ249554A patent/NZ249554A/en unknown
- 1993-03-08 RU RU94043771A patent/RU2141952C1/ru active
- 1993-03-08 JP JP51547193A patent/JP3450854B2/ja not_active Expired - Fee Related
- 1993-03-08 CA CA002131693A patent/CA2131693A1/en not_active Abandoned
- 1993-03-08 DK DK93905536T patent/DK0630368T3/da active
- 1993-03-08 ZA ZA931647A patent/ZA931647B/xx unknown
- 1993-03-08 WO PCT/GB1993/000479 patent/WO1993018009A1/en active IP Right Grant
- 1993-03-08 AT AT93905536T patent/ATE170846T1/de not_active IP Right Cessation
- 1993-03-08 CZ CZ942094A patent/CZ209494A3/cs unknown
- 1993-03-08 DE DE69320945T patent/DE69320945T2/de not_active Expired - Fee Related
- 1993-03-08 AU AU36432/93A patent/AU672597B2/en not_active Ceased
- 1993-03-08 ES ES93905536T patent/ES2123048T3/es not_active Expired - Lifetime
- 1993-05-27 TW TW082104263A patent/TW366339B/zh active
-
1994
- 1994-09-08 FI FI944134A patent/FI944134A/fi unknown
- 1994-09-09 KR KR1019940703149A patent/KR950700887A/ko not_active Application Discontinuation
- 1994-09-09 US US08/304,006 patent/US5534535A/en not_active Expired - Lifetime
-
1995
- 1995-09-11 KR KR1019970701554A patent/KR970705547A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL104976A0 (en) | 1993-07-08 |
| DE69320945D1 (de) | 1998-10-15 |
| WO1993018009A1 (en) | 1993-09-16 |
| AU672597B2 (en) | 1996-10-10 |
| EP0630368B1 (en) | 1998-09-09 |
| US5534535A (en) | 1996-07-09 |
| JP3450854B2 (ja) | 2003-09-29 |
| HUT68445A (en) | 1995-06-28 |
| JPH07506816A (ja) | 1995-07-27 |
| ZA931647B (en) | 1994-09-08 |
| HU9402582D0 (en) | 1994-11-28 |
| CZ209494A3 (en) | 1995-11-15 |
| FI944134A0 (fi) | 1994-09-08 |
| RU94043771A (ru) | 1996-08-10 |
| KR950700887A (ko) | 1995-02-20 |
| AU3643293A (en) | 1993-10-05 |
| GB9205071D0 (en) | 1992-04-22 |
| IL104976A (en) | 1998-10-30 |
| DK0630368T3 (da) | 1999-06-07 |
| TW366339B (en) | 1999-08-11 |
| ATE170846T1 (de) | 1998-09-15 |
| NZ249554A (en) | 1996-05-28 |
| EP0630368A1 (en) | 1994-12-28 |
| DE69320945T2 (de) | 1999-02-04 |
| KR970705547A (ko) | 1997-10-09 |
| CA2131693A1 (en) | 1993-09-16 |
| ES2123048T3 (es) | 1999-01-01 |
| RU2141952C1 (ru) | 1999-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE170846T1 (de) | Antivirale nukleosidanaloge | |
| DK169991A (da) | Antivirale forbindelser | |
| DE3780581D1 (de) | Antiviralen phosphonomethoxyalkylen-purin- und -pyrimidin-derivate. | |
| DE19975068I2 (de) | Derivate und Analoge der 2-Deoxy-2,3-Didehydro-N-Acetyl-Neuraminsaeure und ihre Verwendung als antivirale Agentien | |
| DK1280813T3 (da) | Antivirale pyrimidin-nukleosidanaloger | |
| DK214787D0 (da) | Furo-(3,4-d)-pyrimidin-2,4-dionderivater samt mel-lemprodukter deraf | |
| ATE63747T1 (de) | Antivirale verbindungen. | |
| MX9203217A (es) | Nucleosidos terapeuticos. | |
| ATE36331T1 (de) | Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung. | |
| EP0453247A3 (en) | Anti-viral compounds |